MPG.eBooks - Description: C1 esterase inhibitor for prophylaxis against hereditary angioedema attacks

Cover Image

Read Now

C1 esterase inhibitor for prophylaxis against hereditary angioedema attacks a review of the clinical effectiveness, cost-effectiveness, and guidelines

The purpose of this review is to assess evidence on the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the prophylactic use of C1 esterase inhibitor (C1-INH) against hereditary angioedema (HAE) attacks

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	[Ottawa] Canadian Agency for Drugs and Technologies in Health 24 April 2015, 2015
Series:	Rapid response report : summary with critical appraisal
Subjects:	Complement C1 Inhibitor Protein / Therapeutic Use Angioedemas, Hereditary / Prevention & Control
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK304769
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The purpose of this review is to assess evidence on the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the prophylactic use of C1 esterase inhibitor (C1-INH) against hereditary angioedema (HAE) attacks
Item Description:	Title from PDF title caption
Physical Description:	1 PDF file (26 pages) illustration